Given that activation of IRE1α-XBP1 is closely related to AD pathology, we first investigated the effects of Aβ25–35 on the activation of IRE1α signaling by determining the levels of the phosphorylated form of IRE1α and spliced-XBP1. The gene discussed is ERN1; the disease is Alzheimer disease.